17-Hydroxy Progesterone (Neonatal Screen) Test50+ booked in last 3 days
This test checks for Congenital Adrenal Hyperplasia in the newborn using 17-OHP as the marker analyte.
Frequently Asked Questions
This test is required to: identify at-risk babies at the earliest for congenital adrenal hyperplasia.
This is a screening test for newborn babies usually done within 48-72 hours of birth to detect Congenital Adrenal Hyperplasia .
Newborn Screening is a test that involves testing of infants at birth for certain genetically linked metabolic disorders which may affect baby’s physical, mental and intellectual development. This test checks for Congenital Adrenal Hyperplasia in the newborn using 17-OHP as the marker analyte.
Ratings & Reviews (0)
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.